Startseite/Aktien/SXTPW

SXTPW

60 Degrees Pharmaceuticals Inc. Warrant

$0.052+0.000 (0.000%)

Echtzeitkurs

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.000

Hoch

$0.000

Tief

$0.000

Volumen

0.00M

Unternehmensfundamentaldaten

Handelsstatistiken

Ähnliche Nachrichten

3. Juni 2025 · 12:49

GlobeNewswire

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000A full 45 percent of persistent babesiosis cases include chronic fatigueHealthcare providers treating

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

15. Mai 2025 · 20:31

GlobeNewswire

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand.Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;